Clinical Review Criteria Procedural Treatments for Epilepsy
Customize your policy alerts
Sign up for all Kaiser Permanente policy alerts
Know when Kaiser Permanente releases new policies or updates existing guidance.
Monitor payer policy activity
Governs medical necessity and coverage criteria for non-invasive and implantable vagus nerve stimulation, deep brain stimulation, and responsive neurostimulation for epilepsy and other listed indications for Medicare and non-Medicare members in Washington.
Clinical criteria for deep brain stimulation as adjunctive treatment for adults with refractory focal epilepsy were approved.
Clinical criteria for Responsive Neurostimulation using the NeuroPace system were adopted.
A medical technology assessment review for the gammaCore Sapphire non-invasive vagus nerve stimulator was added.
Applicable procedure codes were updated.
Clinical criteria were added for deep brain stimulation as adjunctive treatment for adults with refractory focal epilepsy who are not candidates for other surgical options.
Applicable procedure codes were updated in the revision history.
Clinical criteria for responsive neurostimulation were added in a prior revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.